195 related articles for article (PubMed ID: 24633919)
1. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G
Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919
[TBL] [Abstract][Full Text] [Related]
2. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
[TBL] [Abstract][Full Text] [Related]
3. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic efficacy of intracarotid infusion of 20% mannitol with ACNU in Fischer rats with intracerebrally implanted 9L gliosarcoma].
Miyagami M; Tazoe M; Kasahara E; Tsubokawa T
Gan To Kagaku Ryoho; 1989 May; 16(5):2059-65. PubMed ID: 2499268
[TBL] [Abstract][Full Text] [Related]
5. Intracerebral administration of heat-inactivated Staphylococcus epidermidis enhances oncolysis and prolongs survival in a 9L orthotopic gliosarcoma model.
Löhr M; Molcanyi M; Poggenborg J; Spuentrup E; Runge M; Röhn G; Härtig W; Hescheler J; Hampl JA
Cell Physiol Biochem; 2013; 31(4-5):614-24. PubMed ID: 23652608
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of survival of 9L gliosarcoma bearing rats following intracerebral delivery of drugs in combination with microbeam radiation therapy.
Régnard P; Bräuer-Krisch E; Troprès I; Keyriläinen J; Bravin A; Le Duc G
Eur J Radiol; 2008 Dec; 68(3 Suppl):S151-5. PubMed ID: 18635331
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility and relative stability in magnetic resonance imaging indices of tumor vascular physiology over a period of 24h in a rat 9L gliosarcoma model.
Nagaraja TN; Elmghirbi R; Brown SL; Schultz LR; Lee IY; Keenan KA; Panda S; Cabral G; Mikkelsen T; Ewing JR
Magn Reson Imaging; 2017 Dec; 44():131-139. PubMed ID: 28887206
[TBL] [Abstract][Full Text] [Related]
8. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
9. Response of rat intracranial 9L gliosarcoma to microbeam radiation therapy.
Dilmanian FA; Button TM; Le Duc G; Zhong N; Peña LA; Smith JA; Martinez SR; Bacarian T; Tammam J; Ren B; Farmer PM; Kalef-Ezra J; Micca PL; Nawrocky MM; Niederer JA; Recksiek FP; Fuchs A; Rosen EM
Neuro Oncol; 2002 Jan; 4(1):26-38. PubMed ID: 11772430
[TBL] [Abstract][Full Text] [Related]
10. 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N'-(4-butyl-2-methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A.
Guo M; Roman RJ; Fenstermacher JD; Brown SL; Falck JR; Arbab AS; Edwards PA; Scicli AG
J Pharmacol Exp Ther; 2006 Apr; 317(1):97-108. PubMed ID: 16352703
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps.
Badruddoja MA; Krouwer HG; Rand SD; Rebro KJ; Pathak AP; Schmainda KM
Neuro Oncol; 2003 Oct; 5(4):235-43. PubMed ID: 14565159
[TBL] [Abstract][Full Text] [Related]
12. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L
PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510
[TBL] [Abstract][Full Text] [Related]
13. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
14. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
Ram Z; Walbridge S; Shawker T; Culver KW; Blaese RM; Oldfield EH
J Neurosurg; 1994 Aug; 81(2):256-60. PubMed ID: 8027810
[TBL] [Abstract][Full Text] [Related]
15. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas.
Barth RF
J Neurooncol; 1998 Jan; 36(1):91-102. PubMed ID: 9525831
[TBL] [Abstract][Full Text] [Related]
16. A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats.
Fleshner M; Watkins LR; Redd JM; Kruse CA; Bellgrau D
Cell Transplant; 1992; 1(4):307-12. PubMed ID: 1344303
[TBL] [Abstract][Full Text] [Related]
17. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
18. Brain tumor vessel response to synchrotron microbeam radiation therapy: a short-term in vivo study.
Serduc R; Christen T; Laissue J; Farion R; Bouchet A; Sanden Bv; Segebarth C; Bräuer-Krisch E; Le Duc G; Bravin A; Rémy C; Barbier EL
Phys Med Biol; 2008 Jul; 53(13):3609-22. PubMed ID: 18560052
[TBL] [Abstract][Full Text] [Related]
19. Synchrotron microbeam radiation therapy for rat brain tumor palliation-influence of the microbeam width at constant valley dose.
Serduc R; Bouchet A; Bräuer-Krisch E; Laissue JA; Spiga J; Sarun S; Bravin A; Fonta C; Renaud L; Boutonnat J; Siegbahn EA; Estève F; Le Duc G
Phys Med Biol; 2009 Nov; 54(21):6711-24. PubMed ID: 19841517
[TBL] [Abstract][Full Text] [Related]
20. Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.
Bow H; Hwang LS; Schildhaus N; Xing J; Murray L; Salditch Q; Ye X; Zhang Y; Weingart J; Brem H; Tyler B
J Neurosurg; 2014 Mar; 120(3):662-9. PubMed ID: 24359008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
